Sirona Biochem Corp. (TSXV:SBM)

Intercept Pharmaceuticals Revenue

Sirona Biochem had revenue of 2.54K CAD in the quarter ending July 31, 2024, a decrease of -62.69%. This brings the company's revenue in the last twelve months to -16.36K, down -119.39% year-over-year. In the fiscal year ending October 31, 2023, Sirona Biochem had annual revenue of 34.78K, down -94.82%.

• Revenue (ttm): -16.36K
• Revenue Growth: -119.39%
• P/S Ratio: -940.37
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 15.39M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2023	34.78K	-637.14K	-94.82%
Oct 31, 2022	671.92K	403.90K	150.70%
Oct 31, 2021	268.02K	162.31K	153.54%
Oct 31, 2020	105.71K	-30.03K	-22.12%
Oct 31, 2019	135.74K	-1.14M	-89.38%